154 related articles for article (PubMed ID: 3890627)
21. Effects of heparin-induced non-esterified free fatty acid on minimal model-derived insulin sensitivity in individuals with varying degrees of glucose intolerance.
Osei K; Schuster DP
Diabet Med; 1995 Oct; 12(10):911-5. PubMed ID: 8846683
[TBL] [Abstract][Full Text] [Related]
22. A numerical deconvolution method to estimate C-peptide secretion in humans after an intravenous glucose tolerance test.
Boston RC; Pei D; Moate PJ
Metabolism; 2009 Jul; 58(7):891-900. PubMed ID: 19394979
[TBL] [Abstract][Full Text] [Related]
23. The hot but not the cold minimal model allows precise assessment of insulin sensitivity in NIDDM subjects.
Avogaro A; Vicini P; Valerio A; Caumo A; Cobelli C
Am J Physiol; 1996 Mar; 270(3 Pt 1):E532-40. PubMed ID: 8638702
[TBL] [Abstract][Full Text] [Related]
24. Practical application of methods for in vivo assessment of insulin secretion and action.
Best JD; Alford FP; Martin IK; Pestell RG; Ward GM
Horm Metab Res Suppl; 1990; 24():60-6. PubMed ID: 2272628
[TBL] [Abstract][Full Text] [Related]
25. Integrated model of hepatic and peripheral glucose regulation for estimation of endogenous glucose production during the hot IVGTT.
Krudys KM; Dodds MG; Nissen SM; Vicini P
Am J Physiol Endocrinol Metab; 2005 May; 288(5):E1038-46. PubMed ID: 15632105
[TBL] [Abstract][Full Text] [Related]
26. Insulin sensitivity and secretion changes after gastric bypass in normotolerant and diabetic obese subjects.
Salinari S; Bertuzzi A; Guidone C; Previti E; Rubino F; Mingrone G
Ann Surg; 2013 Mar; 257(3):462-8. PubMed ID: 23388352
[TBL] [Abstract][Full Text] [Related]
27. Choosing an optimal input for an intravenous glucose tolerance test to aid parameter identification.
Martin EC; Yates JWT; Ogungbenro K; Aarons L
J Pharm Pharmacol; 2017 Oct; 69(10):1275-1283. PubMed ID: 28653461
[TBL] [Abstract][Full Text] [Related]
28. The integrated glucose insulin minimal model: An improved version.
Ibrahim MMA; Largajolli A; Karlsson MO; Kjellsson MC
Eur J Pharm Sci; 2019 Jun; 134():7-19. PubMed ID: 30978382
[TBL] [Abstract][Full Text] [Related]
29. A minimal model of insulin secretion and kinetics to assess hepatic insulin extraction.
Toffolo G; Campioni M; Basu R; Rizza RA; Cobelli C
Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E169-E176. PubMed ID: 16144811
[TBL] [Abstract][Full Text] [Related]
30. Insulin secretion and insulin sensitivity in diabetic and non-diabetic subjects with hepatic nuclear factor-1alpha (maturity-onset diabetes of the young-3) mutations.
Vaxillaire M; Pueyo ME; Clément K; Fiet J; Timsit J; Philippe J; Robert JJ; Tappy L; Froguel P; Velho G
Eur J Endocrinol; 1999 Dec; 141(6):609-18. PubMed ID: 10601964
[TBL] [Abstract][Full Text] [Related]
31. A mathematical model for insulin kinetics and its application to protein-deficient (malnutrition-related) diabetes mellitus (PDDM).
Bajaj JS; Subba Rao G; Subba Rao J; Khardori R
J Theor Biol; 1987 Jun; 126(4):491-503. PubMed ID: 3116347
[TBL] [Abstract][Full Text] [Related]
32. NONMEM improves group parameter estimation for the minimal model of glucose kinetics.
De Gaetano A; Mingrone G; Castageneto M
Am J Physiol; 1996 Nov; 271(5 Pt 1):E932-7. PubMed ID: 8944683
[TBL] [Abstract][Full Text] [Related]
33. Assessment of hepatic insulin action in obese type 2 diabetic patients.
Staehr P; Hother-Nielsen O; Levin K; Holst JJ; Beck-Nielsen H
Diabetes; 2001 Jun; 50(6):1363-70. PubMed ID: 11375337
[TBL] [Abstract][Full Text] [Related]
34. [Effect of oral contraceptives on plasma insulin and blood glucose levels after long term use (author's transl)].
Muck BR; Hommel G
Arch Gynakol; 1976; 221(1):61-72. PubMed ID: 989269
[TBL] [Abstract][Full Text] [Related]
35. Insulin secretion and insulin sensitivity in diabetic subgroups: studies in the prediabetic and diabetic state.
Tripathy D; Carlsson AL; Lehto M; Isomaa B; Tuomi T; Groop L
Diabetologia; 2000 Dec; 43(12):1476-83. PubMed ID: 11151756
[TBL] [Abstract][Full Text] [Related]
36. Insulin production rate, hepatic insulin retention and splanchnic carbohydrate metabolism after oral glucose ingestion in hyperinsulinaemic Type 2 (non-insulin-dependent) diabetes mellitus.
Waldhäusl W; Bratusch-Marrain P; Gasić S; Korn A; Nowotny P
Diabetologia; 1982 Jul; 23(1):6-15. PubMed ID: 6749586
[TBL] [Abstract][Full Text] [Related]
37. Non-insulin-mediated glucose disappearance in subjects with IDDM. Discordance between experimental results and minimal model analysis.
Quon MJ; Cochran C; Taylor SI; Eastman RC
Diabetes; 1994 Jul; 43(7):890-6. PubMed ID: 8013753
[TBL] [Abstract][Full Text] [Related]
38. Effect of cyproheptadine administration on insulin secretion in acromegalic, diabetic and normal subjects.
Feldman JM; Bivens CH; Skyler JS; Lebovitz HE
Horm Metab Res; 1975 Jul; 7(4):279-83. PubMed ID: 1150128
[TBL] [Abstract][Full Text] [Related]
39. Reproducibility and comparability of insulin sensitivity indices measured by stable-label intravenous glucose tolerance test.
Hovorka R; Bannister P; Eckland DJ; Halliday D; Murley DN; Rees SE; Young MA
Diabet Med; 1998 Mar; 15(3):234-46. PubMed ID: 9545125
[TBL] [Abstract][Full Text] [Related]
40. Dose-response relation between plasma-insulin and blood-glucose levels during oral glucose loads in prediabetic and diabetic subjects.
Cerasi E; Ependić S; Luft R
Lancet; 1973 Apr; 1(7807):794-7. PubMed ID: 4121221
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
